Aevo vs Mitosis — how do they compare? Aevo trades at Rp343.47 (market cap Rp320,62M, Rp55,76M 24h volume), while Mitosis trades at Rp450.18 (market cap Rp81,64M, Rp75,67M 24h volume). The key difference: Aevo is far larger — about 3.9× Mitosis's market cap, and Aevo's circulating supply is 932,6M / 1B AEVO (94%) versus 181,3M / 1B MITO (19%) for Mitosis. Which is the better fit depends on your goals — on Pluang, investors hold Aevo for 89 Days and Mitosis for 20 Days on average.
| AEVO | MITO | |
|---|---|---|
Market Cap | Rp320,62M | Rp81,64M |
Volume (24h) | Rp55,76M | Rp75,67M |
Circulating Supply | 932,6M / 1B AEVO (94%) | 181,3M / 1B MITO (19%) |
Typical Hold Time | 89 Days | 20 Days |
What Pluang investors did over the last 30 days
Aevo is the world's first high-performance decentralized options exchange. The exchange runs on a custom EVM roll-up that rolls up to Ethereum. Aevo operates an off-chain orderbook with on-chain settlements. This means that once orders are matched, trades get executed and settled with smart contracts.
Read more on AEVO →Mitosis is a cross-chain DeFi protocol that converts liquidity positions into programmable and composable assets. It tackles two significant inefficiencies in decentralized finance: the illiquidity of staked assets and limited access to high-yield opportunities for smaller users.
Read more on MITO →